GABRIELLE MILLER: Open Payments
NPI 1275172744 · MOORESVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,337 in 116 payments from 27 companies in 2025. Trend: 2023 $1,658 · 2024 $1,237 · 2025 $2,337
Food & beverage: $2,253Education: $84
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 16 | $507 |
| Novo Nordisk Inc | 13 | $281 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 17 | $220 |
| ABBVIE INC. | 12 | $198 |
| Lilly USA, LLC | 10 | $170 |
| IBSA Pharma Inc. | 7 | $140 |
| SANOFI-AVENTIS U.S. LLC | 5 | $131 |
| Madrigal Pharmaceuticals | 5 | $108 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $74 |
| Phathom Pharmaceuticals, Inc. | 3 | $51 |
Products named: TREMFYA, XIFAXAN, Rybelsus, Tirosint, TZIELD, REZDIFFRA, DUPIXENT, ENTYVIO.
Industry payments across NC — which companies pay providers there.
